Identification of molecular mechanisms and the targets using in vitro carcinogenesis model of endometrial cancer.
Project/Area Number |
20390432
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Obstetrics and gynecology
|
Research Institution | Kanazawa University |
Principal Investigator |
KYO Satoru Kanazawa University, 医学系, 講師 (50272969)
|
Co-Investigator(Kenkyū-buntansha) |
MIZUMOTO Yasunari 金沢大学, 附属病院, 助教 (00420331)
|
Project Period (FY) |
2008 – 2010
|
Project Status |
Completed (Fiscal Year 2010)
|
Budget Amount *help |
¥19,240,000 (Direct Cost: ¥14,800,000、Indirect Cost: ¥4,440,000)
Fiscal Year 2010: ¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2009: ¥6,240,000 (Direct Cost: ¥4,800,000、Indirect Cost: ¥1,440,000)
Fiscal Year 2008: ¥8,840,000 (Direct Cost: ¥6,800,000、Indirect Cost: ¥2,040,000)
|
Keywords | 子宮内膜癌 / 癌化モデル / 分子標的 |
Research Abstract |
In the present study, we investigated the molecular targets of KRAS signals using tumorigenic cells with oncogenic KRAS mutation established from TERT-immortalized endometrial epithelial cells. We first confirmed that the Raf-Erk pathway, but not the PI3K-Akt pathway, was activated in KRAS-tumorigenic cells. However, the introduction of constitutively active MEK into immortalized cells to mimic Raf-Erk activation failed to obtain tumorigenic phenotypes, indicating the existence of other carcinogenic pathways triggered by KRAS Recent evidence suggestive of linkage with KRAS signals prompted us to examine the involvement of NF-κB in endometrial carcinogenesis. We found that the DNA binding activity of NF-κB was markedly elevated in KRAS-tumorigenic cells compared to TERT-immortalized cells. Furthermore, the ability of NF-κB to activate the target gene promoters significantly increased in KRAS-tumorigenic cells. Introduction of a mutant IκB that is resistant to degradation and thereby enhances the inhibitory effect on NF-κB largely abrogated the transformed phenotypes of KRAS-tumorigenic cells. Thus, oncogenic KRAS signals contributed to the tumorigenic phenotypes of endometrial cells by activating the transcription function of NF-κB. These findings clearly show that NF-κB activation is a novel target of oncogenic KRAS in endometrial carcinogenesis, implying the potential utility of NF-κB inhibitors for endometrial cancer chemoprevention, especially with KRAS mutation.
|
Report
(4 results)
Research Products
(39 results)
-
-
-
[Journal Article] Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.2011
Author(s)
Kyo S, Sakaguchi J, Kiyono T, Shimizu Y, Maida Y, Mizumoto Y, Mori N, Nakamura M, Takakura M, Miyake M, Sakamoto M, Inoue M.
-
Journal Title
Clin.Cancer Res. 17
Pages: 525-537
Related Report
Peer Reviewed
-
-
-
[Journal Article] In vivo biological purging for lymph node metastasis of human colorectal cancer by telomerase-specific incolytic virotherapy.2010
Author(s)
Kojima T, Watanabe Y, Hashimoto Y, Kuroda S, Yamasaki Y, Yano S, Ouchi M, Tazawa H, Uno F, Kagawa S, Kyo S, Mizuguchi H, Urata Y, Tanaka N, Fujiwara T.
-
Journal Title
Ann. Surg. 251
Pages: 1079-1086
Related Report
Peer Reviewed
-
-
[Journal Article] Prognostic impact of CD133 expression as a tumor intiating marker in endometrial cancer.2010
Author(s)
Nakamura M, Kyo S, Zhang B, Zhang X, Mizumoto Y, Takakura M, Maids Y, Mori N, Hashimoto M, Ohno S, Inoue M.
-
Journal Title
Hum.Pathol. 41
Pages: 1516-1529
Related Report
Peer Reviewed
-
[Journal Article] A novel translational approach for human Malignant pleural mesothelioma : paranase-assisted dual virotherapy.2010
Author(s)
Watanabe Y, Kojima T, Kagawa S, Uno F, Hashimoto Y, Kyo S, Mizuguchi H, Tanaka N, Kawamura H, Ichimaru D, braid Y, Fujiwara T.
-
Journal Title
Oncogene 29
Pages: 1145-1154
Related Report
Peer Reviewed
-
-
-
-
-
-
[Journal Article] A simple biological imaging system for detecting viable human circulating tumor cells.2009
Author(s)
Kojima T, Hashimoto Y, Watanabe Y, Kagawa S, Uno F, Kuroda S, Tazawa H, Kyo S, Mizuguchi H, Urata Y, Tanaka N, Fujiwara T.
-
Journal Title
J.Clin.Invest. 119
Pages: 3172-3181
NAID
Related Report
Peer Reviewed
-
-
-
-
-
-
[Journal Article] Activation of telomerase by human cytomegalovirus.2009
Author(s)
Straat K, Liu C, Rahbar A, Zhu Q, Liu L, Wolmer-Solberg N, Lou F, Liu Z, Shen J, Jib J, Kyo S, Bjorkholm M,Sjlberg J, Soderberg-Naucl er C, Xu D.
-
Journal Title
J Natl Cancer Inst. 101
Pages: 488-497
Related Report
Peer Reviewed
-
[Journal Article] Telomerase-Specific Virotheranostics for Human Head and Neck Cancer.2009
Author(s)
Kurihara Y, Watanabe Y, Onimatsu H, Kojima T, Shirota T, Hatori M, Liu D, Kyo S, Mizuguchi H, Urata Y, Shintani S, Fujiwara T.
-
Journal Title
Clin Cancer Res. 15
Pages: 2335-2343
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Diagnostic potential and limitation of imaging cancer cell in cytological sample using telomerase-specific replicative adenovirus.2009
Author(s)
Maida Y, Kyo S, Sakaguchi J, Mizumoto Y, Hashimoto M, Mori M, Ikoma T, Nakamura M, Takakura M, Urata Y, Fujiwara T, Tnoue M.
-
Journal Title
Int.J.Oncol. 34
Pages: 1549-1556
Related Report
Peer Reviewed
-
-
-
-
-
[Journal Article] Novel Cardiac Precursor-Like Cells from Human Menstrual Blood-Derived Mesenchymal Cells.2008
Author(s)
Hida N, Nishiyama N, Miyoshi S, Kira S, Segawa K, Uyama T, Mori T, Miyado K, Ikegami Y, Cui C, Kiyono T, Kyo S, Shimizu T, Okano T, Sakamoto M, Ogawa S, Umezawa A.
-
Journal Title
Stem Cells. 26
Pages: 1695-1704
Related Report
Peer Reviewed
-
-
[Journal Article] Role of menin in the regulation of telomerase activity in normal and cancer cells.2008
Author(s)
Hashimoto M, Kyo S, Hua X, Tahara H, Nakajima M, Takakura M, Saskaguchi J, Maida Y, Nakamura M, Ikoma T, Mori N, Mizumoto Y, Inoue M.
-
Journal Title
Int.J.Oncol. 33
Pages: 333-340
Related Report
Peer Reviewed
-
-
-
-
-
-